Physician profile
James Darnley
NPI 1144726910
$11,863.47
in general payments reported to CMS, 2019-2025
11 companies · $2,140 in 2025
The $2,140 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,309 · 2021: $1,215 · 2022: $2,616 · 2023: $2,353 · 2024: $2,231 · 2025: $2,140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,287 · Food and Beverage: $3,149 · Education: $287.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,287.48 |
| Food and Beverage | $3,149.35 |
| Education | $287.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rock Medical Orthopedics, INC. | $3,947.15 | 2020-2022 | |
| Stryker Corporation | $2,911.08 | 2023-2025 | Pangea, Pro, T2 Alpha |
| Smith+Nephew, INC. | $2,162.02 | 2023-2025 | Evos, Trigen, Trigen Intertan |
| Arthrex, INC. | $1,173.41 | 2022 | |
| Synthes Gmbh | $1,071.01 | 2024 | |
| Osteocentric Technologies, INC. | $197.61 | 2024 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Depuy Synthes Sales INC. | $163.77 | 2024-2025 | Na, Tfn-Advance, Motoband |
| Medical Device Business Services, INC. | $122.11 | 2024 | Na |
| Vericel Corporation | $56.55 | 2022-2023 | Maci |
| Si-Bone, INC. | $36.54 | 2024 | |
| Kerecis Limited | $22.22 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Darnley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.